Cargando…

COVID-19: impact of vaccination in myeloma patients

Detalles Bibliográficos
Autores principales:	Hoornaert, E., Dachy, F., Hansenne, A., Bailly, S., van Maanen, A., Gruson, D., Vekemans, M-C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001015/ https://www.ncbi.nlm.nih.gov/pubmed/35411439 http://dx.doi.org/10.1007/s00277-022-04799-7

Ejemplares similares

P-147: COVID-19, impact of vaccination in myeloma patients
por: Hoornaert, Ellen, et al.
Publicado: (2021)

COVID-19, impact on myeloma patients
por: Dufour, Inès, et al.
Publicado: (2020)

Clinical impact of COVID-19 on a French population of spondyloarthritis patients
por: Roux, Christian Hubert, et al.
Publicado: (2020)

Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
por: Bitoun, Samuel, et al.
Publicado: (2021)

Severe COVID-19-induced AKI: a 3-month follow-up
por: Orieux, Arthur, et al.
Publicado: (2021)

The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma
por: Elsabah, Hesham, et al.
Publicado: (2020)

Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?
por: Tailor, Imran K., et al.
Publicado: (2020)

Global impact of vaccine nationalism during COVID-19 pandemic
por: Riaz, Mehr Muhammad Adeel, et al.
Publicado: (2021)

Pfizer: The miracle vaccine for COVID-19?
por: Badiani, A.A., et al.
Publicado: (2020)

Governments and vaccination against COVID-19()
por: Javier Silva, L.A., et al.
Publicado: (2021)

Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice
por: Fouquet, G., et al.
Publicado: (2021)

COVID-19 vaccination on Brazil and the crocodile side-effect
por: Boschiero, M.N., et al.
Publicado: (2021)

Inhibiting MEK in MAPK pathway-activated myeloma
por: Heuck, C J, et al.
Publicado: (2016)

Ensuring access to COVID-19 vaccines among marginalised populations in Africa
por: Lucero-Prisno, D.E., et al.
Publicado: (2021)

Covid-19, vaccine decision and schizophrenia
por: Samaâli, S., et al.
Publicado: (2023)

Acute macular neuroretinopathy after COVID-19 vaccine
por: Michel, T., et al.
Publicado: (2022)

MMSET is the key molecular target in t(4;14) myeloma
por: Mirabella, F, et al.
Publicado: (2013)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccines
por: Syed, Mohamed Ahmed, et al.
Publicado: (2022)

Relapse of immune thrombocytopenia after COVID‐19 vaccination
por: van Dijk, Wobke E. M., et al.
Publicado: (2021)

Significant impact of vaccination on length of hospital stay and survival in hospitalized patients with COVID-19()
por: Leuning, D.G., et al.
Publicado: (2022)

Persistent pruritus following COVID-19 vaccination
por: Doyle, C., et al.
Publicado: (2022)

The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies
por: Paget, John, et al.
Publicado: (2020)

COVID-19 and vaccination, or the new misfortunes of the precautionary principle
por: Ivasilevitch, A., et al.
Publicado: (2021)

BCG vaccination and COVID-19: Much ado about nothing?
por: Caminati, M., et al.
Publicado: (2020)

COVID-19 infection associated with autoimmune hemolytic anemia
por: Capes, Antoine, et al.
Publicado: (2020)

Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients
por: Bera, T K, et al.
Publicado: (2018)

COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period
por: Bansal, N., et al.
Publicado: (2021)

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
por: Whitaker, Heather J, et al.
Publicado: (2021)

The ethics of COVID-19 vaccine distribution
por: Nichol, Ariadne A., et al.
Publicado: (2021)

Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
por: Crespo Burillo, J.A., et al.
Publicado: (2021)

Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005)

Digital markers of sleep architecture to characterize the impact of different lockdown regimens on sleep health during the COVID-19 pandemic
por: Pépin, Jean-Louis, et al.
Publicado: (2022)

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
por: Maura, F, et al.
Publicado: (2018)

COVID-19 Vaccination in Patients With Membranous Nephropathy
por: Visch, Ruben, et al.
Publicado: (2022)

Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
por: Agharbi, F.-Z., et al.
Publicado: (2022)

COVID-19 vaccine: Risk of inequality and failure of public health strategies
por: Cioffi, A., et al.
Publicado: (2021)

The impact of COVID-19 on indigenous people in Africa
por: Aborode, A.T., et al.
Publicado: (2021)

Mass culling of minks to protect the COVID-19 vaccines: is it rational?
por: Frutos, R., et al.
Publicado: (2020)

Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre
por: Garvey, Mark I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_on6pbti59sola7914ifnrvego9